Patent · US Active

Human binding molecules having killing activity against enterococci and uses thereof

US8241631B2 · kind B2 · utility

31Cited by

12References

10Claims

0Family size

Assignee

Crucell Holland B.V. · NL

Inventors

Mark Throsby · Utrecht, NL
Robert A. Kramer · Crown Point, US
Cornelis Adriaan De Kruif · De Bilt, NL

Key dates

Filing date	May 19, 2011
Grant date	Aug 14, 2012
Priority date	—
Expiry date	May 19, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/21
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described are human binding molecules specifically binding to enterococci and having killing activity against enterococci, nucleic acid molecules encoding the human binding molecules, compositions comprising the human binding molecules and methods of identifying or producing the human binding molecules. The human binding molecules can be used in the diagnosis, prophylaxis, and/or treatment of a condition resulting from Enterococcus.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.